ALLO Earnings

Quarterly EPS
$-0.28
Q4 2024
$-0.28
Q1 2025
$-0.23
Q2 2025
$-0.19
Q3 2025
$-0.17
Q4 2025
$-0.18
Q1 2026
$-0.13
Q2 2026
$-0.15
Q3 2026
Latest RevenueN/A
Latest Net Income-50369000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q3 2026-$0.150-50369000—+21.1%
Q2 2026-$0.134.6M-42677000—+43.5%
Q1 2026-$0.180-42607000—+35.7%
Q4 2025-$0.170-38810000—+39.3%
Q3 2025-$0.190-41400000—+40.6%
Q2 2025-$0.230-50943000—+34.3%
Q1 2025-$0.280-59733000-100.0%+26.3%
Q4 2024-$0.280-59939000-100.0%+45.1%
Q3 2024-$0.320-66293000——
Q2 2024-$0.350-66358000——
Q1 2024-$0.3822.0K-65000000——
Q4 2023-$0.5121.0K-85778000——
Allogene Therapeutics (ALLO) — Earnings